Initial Management of Diabetic Ketoacidosis (DKA)
The initial management of Diabetic Ketoacidosis (DKA) should begin with aggressive fluid resuscitation using isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour during the first hour, followed by continuous intravenous insulin therapy and electrolyte replacement, particularly potassium. 1
Diagnosis and Initial Assessment
- DKA is diagnosed by the triad of hyperglycemia (blood glucose >250 mg/dL), metabolic acidosis (pH <7.3, bicarbonate <15 mEq/L), and moderate ketonuria or ketonemia 1
- Initial laboratory evaluation should include plasma glucose, blood urea nitrogen/creatinine, serum ketones, electrolytes with calculated anion gap, osmolality, urinalysis, arterial blood gases, and complete blood count 1
- Identify potential precipitating factors such as infection, cerebrovascular accident, alcohol abuse, pancreatitis, myocardial infarction, trauma, or medication non-adherence 1
Fluid Resuscitation
- Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour during the first hour to restore circulatory volume and renal perfusion 1
- Subsequent fluid choice depends on hydration status, serum electrolyte levels, and urine output 1
- Total body water deficit in DKA is typically significant and should be corrected within the first 24 hours 1
- Monitor fluid input/output, hemodynamic parameters, and clinical examination to assess progress with fluid replacement 1
Insulin Therapy
- After excluding hypokalemia (K+ <3.3 mEq/L), administer regular insulin as an intravenous bolus of 0.1 units/kg followed by continuous infusion at 0.1 units/kg/hour 1, 2
- If plasma glucose does not fall by 50-75 mg/dL in the first hour, double the insulin infusion rate hourly until a steady glucose decline is achieved 1
- For mild DKA only, subcutaneous or intramuscular insulin can be considered: give a "priming" dose of 0.4-0.6 units/kg (half IV bolus, half SC/IM), followed by 0.1 unit/hour SC/IM 1
- When blood glucose reaches 200-250 mg/dL, add dextrose to IV fluids while continuing insulin infusion at a reduced rate 1, 2
Electrolyte Management
- Potassium replacement is crucial as total body potassium is depleted despite potentially normal or elevated initial serum levels due to acidosis 1
- Once renal function is assured and serum potassium is known, add 20-40 mEq/L potassium to IV fluids when serum levels fall below 5.5 mEq/L 1
- The potassium in solution should be 1/3 KPO₄ and 2/3 KCl or K-acetate 1
- Bicarbonate therapy is generally not recommended unless pH is <6.9, as studies show no improvement in outcomes with its use 1
- Phosphate replacement may be considered in patients with cardiac dysfunction, anemia, respiratory depression, or serum phosphate <1.0 mg/dL 1
Monitoring
- Blood should be drawn every 2-4 hours for determination of serum electrolytes, glucose, BUN, creatinine, osmolality, and venous pH 1
- Venous pH (usually >7.3) and anion gap can be followed to monitor resolution of acidosis rather than repeated arterial blood gases 1
- Direct measurement of β-hydroxybutyrate in blood is preferred for monitoring ketoacidosis resolution, as the nitroprusside method only measures acetoacetic acid and acetone 1
Resolution Criteria and Transition of Care
- DKA resolution is defined as glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, and venous pH ≥7.3 1
- When transitioning from IV to subcutaneous insulin, continue IV insulin for 1-2 hours after starting subcutaneous insulin to prevent rebound hyperglycemia 1
- For patients who are NPO (nothing by mouth), continue IV insulin and supplement with subcutaneous regular insulin as needed 1
- When the patient can eat, start a multiple-dose schedule using a combination of short/rapid-acting and intermediate/long-acting insulin 1
Complications to Monitor
- Cerebral edema is a serious complication, especially in children and adolescents, and can be minimized by avoiding rapid correction of glucose and osmolality 3
- Hypokalemia can develop rapidly with insulin therapy and fluid resuscitation, potentially causing cardiac arrhythmias 2, 3
- Hypoglycemia may occur with overzealous insulin treatment 2
By following this structured approach to DKA management, focusing on fluid resuscitation, insulin therapy, and electrolyte replacement while monitoring for complications, mortality and morbidity can be significantly reduced.